Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers

Purpose: Diabetic foot ulcers (DFUs) are a leading cause of lower extremity amputations among persons with diabetes (PWD) and a common cause of hospitalizations. This study identified demographic characteristics, lab values, and comorbidities associated with 30-day and 90-day hospital readmission in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Alyson K. Myers MD, Makeda Dawkins MD, Inthuja Baskaran BA, Stephanie Izard MPH, Meng Zhang PhD, Aditya A. Bissoonauth MPH, MBA, CHES, Sally Kaplan RN, CRCC, Amit Rao MD, Mohammad Elzanaty BS, Alisha Oropallo MD, FACS
Formato:	article
Lenguaje:	EN
Publicado:	SAGE Publishing 2021
Materias:	Public aspects of medicine RA1-1270
Acceso en línea:	https://doaj.org/article/da42caf05e3041d09220a9158e24591d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:da42caf05e3041d09220a9158e24591d
record_format	dspace
spelling	oai:doaj.org-article:da42caf05e3041d09220a9158e24591d2021-12-01T22:34:45ZLaboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers0046-95801945-724310.1177/00469580211060779https://doaj.org/article/da42caf05e3041d09220a9158e24591d2021-11-01T00:00:00Zhttps://doi.org/10.1177/00469580211060779https://doaj.org/toc/0046-9580https://doaj.org/toc/1945-7243Purpose: Diabetic foot ulcers (DFUs) are a leading cause of lower extremity amputations among persons with diabetes (PWD) and a common cause of hospitalizations. This study identified demographic characteristics, lab values, and comorbidities associated with 30-day and 90-day hospital readmission in persons with DFU. Methods: A retrospective chart review at our institution examined 397 patients with type 2 diabetes admitted with DFU between January 2014 and December 2018. Variables were analyzed using descriptive statistics, t-tests, and logistic regressions. Results: None of the studied demographic, laboratory (including Hemoglobin A1c) or comorbid diseases were associated with 30-day readmission in persons with DFU. Risk factors for 90-day readmission included discharge location to home with health care (OR: 2.62, 95% CI: 1.39, 4.95), anticoagulant use (OR: 2.36, 95% CI: 1.27, 4.39), and SQ insulin use (OR: 2.08, 95% CI: 1.20, 3.61). Conclusions: None of the variables examined were associated with 30-day readmission; however, potential predictors for 90-day readmission included anticoagulation or insulin use and discharge home with healthcare services. Future studies should devise interventions to improve transition of care in patients with DFU to further assess the role of medications and home health care as a potential predictor of 90-day hospital readmission.Alyson K. Myers MDMakeda Dawkins MDInthuja Baskaran BAStephanie Izard MPHMeng Zhang PhDAditya A. Bissoonauth MPH, MBA, CHESSally Kaplan RN, CRCCAmit Rao MDMohammad Elzanaty BSAlisha Oropallo MD, FACSSAGE PublishingarticlePublic aspects of medicineRA1-1270ENInquiry: The Journal of Health Care Organization, Provision, and Financing, Vol 58 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Public aspects of medicine RA1-1270
spellingShingle	Public aspects of medicine RA1-1270 Alyson K. Myers MD Makeda Dawkins MD Inthuja Baskaran BA Stephanie Izard MPH Meng Zhang PhD Aditya A. Bissoonauth MPH, MBA, CHES Sally Kaplan RN, CRCC Amit Rao MD Mohammad Elzanaty BS Alisha Oropallo MD, FACS Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
description	Purpose: Diabetic foot ulcers (DFUs) are a leading cause of lower extremity amputations among persons with diabetes (PWD) and a common cause of hospitalizations. This study identified demographic characteristics, lab values, and comorbidities associated with 30-day and 90-day hospital readmission in persons with DFU. Methods: A retrospective chart review at our institution examined 397 patients with type 2 diabetes admitted with DFU between January 2014 and December 2018. Variables were analyzed using descriptive statistics, t-tests, and logistic regressions. Results: None of the studied demographic, laboratory (including Hemoglobin A1c) or comorbid diseases were associated with 30-day readmission in persons with DFU. Risk factors for 90-day readmission included discharge location to home with health care (OR: 2.62, 95% CI: 1.39, 4.95), anticoagulant use (OR: 2.36, 95% CI: 1.27, 4.39), and SQ insulin use (OR: 2.08, 95% CI: 1.20, 3.61). Conclusions: None of the variables examined were associated with 30-day readmission; however, potential predictors for 90-day readmission included anticoagulation or insulin use and discharge home with healthcare services. Future studies should devise interventions to improve transition of care in patients with DFU to further assess the role of medications and home health care as a potential predictor of 90-day hospital readmission.
format	article
author	Alyson K. Myers MD Makeda Dawkins MD Inthuja Baskaran BA Stephanie Izard MPH Meng Zhang PhD Aditya A. Bissoonauth MPH, MBA, CHES Sally Kaplan RN, CRCC Amit Rao MD Mohammad Elzanaty BS Alisha Oropallo MD, FACS
author_facet	Alyson K. Myers MD Makeda Dawkins MD Inthuja Baskaran BA Stephanie Izard MPH Meng Zhang PhD Aditya A. Bissoonauth MPH, MBA, CHES Sally Kaplan RN, CRCC Amit Rao MD Mohammad Elzanaty BS Alisha Oropallo MD, FACS
author_sort	Alyson K. Myers MD
title	Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
title_short	Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
title_full	Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
title_fullStr	Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
title_full_unstemmed	Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers
title_sort	laboratory and pharmaceutical data associated with hospital readmission in persons with diabetic foot ulcers
publisher	SAGE Publishing
publishDate	2021
url	https://doaj.org/article/da42caf05e3041d09220a9158e24591d
work_keys_str_mv	AT alysonkmyersmd laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT makedadawkinsmd laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT inthujabaskaranba laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT stephanieizardmph laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT mengzhangphd laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT adityaabissoonauthmphmbaches laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT sallykaplanrncrcc laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT amitraomd laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT mohammadelzanatybs laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers AT alishaoropallomdfacs laboratoryandpharmaceuticaldataassociatedwithhospitalreadmissioninpersonswithdiabeticfootulcers
_version_	1718404130529083392

Laboratory and Pharmaceutical Data Associated With Hospital Readmission in Persons With Diabetic Foot Ulcers

Ejemplares similares